Clinical trials in transplantation often select outcome measures that are short-term or invalidated. To address this, a number of important initiatives have aimed to develop a core outcome set for trials in kidney transplantation, based on shared priorities of all stakeholders. This masterclass will introduce these initiatives and the importance of their incorporation into clinical studies.
“This Masterclass has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”Attendance to the live Masterclass and the completion of the post-event survey are mandatory to receive the certificate and CME credits.
“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”
Presentation: Update on the SONG-Tx initiative, Benedicte Sautenet, France
Live Q&A with Benedicte Sautenet, France
Presentation: What has outcome reporting taught us about equity in access to transplantation? Gabriel Oniscu, UK
Live Q&A with Gabriel Oniscu, UK
Masterclass closing remarks